Tumour clonality was determined by the methylation status of multiple tumour suppressor genes.
The clonality of all of the multiple lesions could be identified by this combined analysis to determine the promoter hypermethylation status of multiple tumour suppressor genes.
We have clearly shown that the methylation status of multiple tumour suppressor genes in multicentric HCC is useful as a clonal marker.
Given the prevalence of DIAPH3 lesions in multiple tumour types, we examined DIAPH3 status in metastases, using PCa as a representative disease model.
Tissue samples were obtained from 19 patients and analysed for the promoter hypermethylation status of multiple tumour suppressor genes (p16, DAP-Kinase, MGMT, GSTP1, APC, RIZ1, SFRP1, SFRP2, SFRP5, RUNX3, and SOCS1) using methylation-specific PCR (MSP).
Imaging correlates for genetic markers would potentially provide an adjunct to histologic assessment by enabling simultaneous evaluation of the whole tumour and multiple tumour sites and by providing an indication of mutation status when tissue sampling has failed.
Taken together, information on genetic status of LKB1 garnered through examining PJS patients and screening multiple tumour types has pointed to LKB1 as an important mediator in the development of cancer.
However, associations between these risk factors and nodal status found in the standard polytomous logistic regression models were no longer significant in models considering multiple tumour characteristics simultaneously (Supplementary Tables 5 and 6 online).
As a monotherapy, the administration of CDNP-R848 in multiple tumour models in mice altered the functional orientation of the tumour immune microenvironment towards an M1 phenotype, leading to controlled tumour growth and protecting the animals against tumour rechallenge.
The importance of neutrophils in the establishment and progression of tumours has been widely reported, with multiple tumour modulatory functions identified.
